Medtronic Puts Spine Business Under Close Evaluation

Medtronic may need to reassess the "strategy and approach” for its spine business if performance doesn't improve, CEO Omar Ishrak said last week. Ishrak did not take a divestiture off the table, but put more emphasis on the potential for internal restructuring.

More from Strategy

More from Business